African swine fever (ASF) is a devastating disease for which there is no vaccine. The ASF virus (ASFV) can infect dendritic cell (DC), but despite the critical role these cells play in induction of adaptive immunity, few studies investigated their response to ASFV infection. We characterized the in vitro interactions of porcine monocytederived DCs (moDC) with a virulent (22653/14), a low virulent (NH/P68) and an avirulent (BA71V) ASFV strain. At a high multiplicity of infection (MOI = 1), all three strains infected immature moDC. Maturation of moDC, with IFN-α/TNF-α, increased susceptibility to infection with 22653/14 and other virulent strains, but reduced susceptibility to NH/P68 and BA71V. The reduced moDC susceptibility to BA71V/NH/P68 was IFN-α mediated, whereas increased susceptibility to 22653/14 was induced by TNF-α. Using an MOI of 0.01, we observed that BA71V replicated less efficiently in moDC compared to the other isolates and we detected increased replication of NH/P68 compared to 22653/14. We observed that BA71V and NH/P68, but not 22653/ 14, downregulated expression of MHC class I on infected cells. All three strains decreased CD16 expression on moDC, whereas ASFV infection resulted in CD80/86 down-regulation and MHC class II DR up-regulation on mature moDC. None of the tested strains induced a strong cytokine response to ASFV and only modest IL-1α was released after BA71V infection. Overall our results revealed differences between strains and suggest that ASFV has evolved mechanisms to replicate covertly in inflammatory DC, which likely impairs the induction of an effective immune response.
Introduction
African swine fever (ASF) is a contagious and often fatal disease of domestic and wild pigs, for which there is no vaccine or treatment available (Sanchez-Vizcaino et al., 2006) . It is currently present in many sub-Saharan African countries, Russian Federation, Trans-Caucasus, East and Central Europe and Sardinia (OIE, WAHIS interface). The aetiological agent is the African swine fever virus (ASFV), a large, enveloped double-stranded DNA virus, which is the only member of the Asfarviridae family (Dixon et al., 2005) .
ASFV infects immune cells of the myeloid lineage. While monocytes and macrophages are considered the primary target cells (Sánchez-Cordón et al., 2008) , ASFV can infect dendritic cells (DC) (Gregg et al., 1995a) . DC are the most potent antigen-presenting cells responsible for the induction of adaptive immune responses against pathogens (Banchereau and Steinman, 1998) . After detection and antigen uptake, DCs migrate into secondary lymphoid tissues to present the processed antigen to T lymphocytes. A maturation step, often achieved by the engagement of pattern recognition receptors with pathogen-associated molecular patterns, is essential for DC to execute their role in an efficient manner (McCullough and Summerfield, 2009) . DC can be broadly divided into two subpopulations: conventional DC (cDC), whose main function is antigen-presentation, and plasmacytoid DC (pDC), specialized in rapidly secreting large amounts of IFN-α (McCullough and Summerfield, 2009 ). Due to the low frequency of DC in the circulation and lymphoid organs, myeloid DC can be generated in vitro from monocytes, through incubation with GM-CSF and IL-4 (Carrasco et al., 2001) . These monocyte-derived DC (moDC) represent a third population of DC, termed inflammatory DC, which are thought to differentiate in vivo during infection and inflammation (Hespel and Moser, 2012 (Carrasco et al., 2001, McCullough and Summerfield, 2009 ). Stimulation of moDC with recombinant IFN-α and TNF-α induces phenotypic maturation, with increased MHC II and CD80/86 surface expression (Carrasco et al., 2004) .
To date, few studies have analysed the interaction of ASFV with DC and none have assessed moDC/ASFV interaction. Previous studies have demonstrated that ASFV can infect dermal DC, resulting in interference with subsequent infection with foot-and-mouth disease virus (Gregg et al., 1995a) . It has been observed that virulent ASFV is able to infect cDC in vivo leading to a reduction in the number of interdigitating cDC in mandibular lymph nodes from three days post-infection, which might limit the development of a protective immune response (Gregg et al., 1995b) . A recent study reported that in vitro infection of enriched blood DC with ASFV induced high levels of type I interferon (IFN), suggesting that ASFV-infected pDC could be a potential source of type I IFN in animals undergoing acute ASF (Golding et al., 2016) . Infection of DC with ASFV is likely to play a critical role in modulating the immune response. Differences might exist also between ASFV strains varying in virulence, since we and others have demonstrated that macrophage cytokine responses differ between attenuated and virulent strains (Gil et al., 2008 , Reis et al., 2016 , Franzoni et al., 2017 .
Considering the central role of DC in initiating a protective immune defence against pathogens, we hypothesized that moDC would respond differently to ASFV strains of spanning the spectrum of virulence, with more pathogenic strains possessing mechanisms to modulate moDC responses in order to evade immune defences. To address these issues, we conducted a thorough in vitro analysis of the interaction of immature and mature moDC with a virulent (22653/14), a low virulent (NH/P68) and an avirulent (BA71V) ASFV strain.
Materials and methods

Animals
Healthy ASFV-naïve cross-bred pigs (Sus scrofa), 4-12 month old, were used in the study. The ASFV negative status of the animals was confirmed by real-time PCR (King et al., 2003) , a commercial antibody ELISA test (Ingenasa, Madrid, Spain) and an immunoblotting test (OIE, 2012) . The animals were housed at the Experiment Station of IZS della Sardegna (Sassari, Italy) and animal housing and handling procedures were performed in accordance with the local ethics committee, in agreement with the guide of use of laboratory animals issued by the Italian Ministry of Health. Heparinized blood was collected by puncture of the cranial vena cava, using a 50 mL syringe containing sodium heparin connected to a 2.0 × 45 mm 14-gauge needle (Delta Med, Mantova, Italy).
Viruses
The tissue-culture adapted avirulent ASFV BA71V strain (kindly provided by the EU ASF Reference Laboratory CISA-INIA, Madrid, Spain) was propagated in vitro by inoculation of sub-confluent monolayers of Vero cells; virus titres were obtained by serial dilution of the virus suspension on Vero cells in 96-well plates, followed by observation for cytopathic effect and crystal violet staining to identify infection rates, as previously described (Carrascosa et al., 2011) . Mock-virus supernatants were prepared in identical manner from uninfected Vero cell cultures ('Mock Vero'). The virulent ASFV field strains 22653/14, 28784/16 (Exotic Disease Laboratory ASF Virus Archive, IZS of Sardinia, Sassari, Italy), Italy/83 (kindly provided by Dr Gian Mario De Mia, Italian ASF Reference Laboratory, CEREP, Italy), Arm07 and Ken06.Bus (kindly provided by the EU ASF Reference Laboratory CISA-INIA, Madrid, Spain), and the low virulent NH/P68 (kindly provided by the EU ASF Reference Laboratory CISA-INIA, Madrid, Spain) were propagated in vitro by inoculation of sub-confluent monolayers of porcine monocytes/macrophages, as previously described (Malmquist and Hay, 1960) . Titres of 22653/14, 28784/16, Italy/83, Arm07, Ken06.Bus ASFV strains were obtained by serial dilution of the virus suspension on monocyte/macrophages in 96-well plates followed by haemadsorption (Malmquist and Hay, 1960) . Viral titres of 22653/14 and the non-haemoadsorbing NH/P68 were obtained by serial dilution of the virus suspension on monocyte/macrophages in 96-well plates followed by immunofluorescence staining (OIE, 2012) . In brief, medium was removed from each well, cell monolayers washed with PBS and fixed by addition of 30% acetone-70% methanol for 15 min. After two washes with PBS, cells were incubated 1 h at 37°C 5% CO 2 with FITC-conjugated anti-ASFV polyclonal antibody (kindly provided by Dr Gian Mario De Mia, Italian ASF Reference Laboratory, CEREP, Italy) diluted 1:200 in PBS and then washed twice with PBS before viewing under a fluorescent microscope (OIE, 2012) . Viral titres were determined using the Spearman-Kärber formula. Mock-virus supernatants were prepared in identical manner from uninfected monocyte/macrophage cultures ('Mock macro'). Partial p72 gene characterization demonstrated that the Sardinian field strains 28784/16 and Italy/83 belonged to genotype I . Additional genotype I strains tested were BA71V, NH/P68, 22653/14 (Gallardo et al., 2009 , Franzoni et al., 2017 , whereas Arm07 and Ken06.Bus belong to genotype II and IX, respectively (Gallardo et al., 2014 , Gallardo et al., 2009 ).
Generation of porcine monocyte-derived dendritic cells and activation
Porcine leukocytes were obtained from heparinized blood, as previously described with slight modifications (OIE, 2012) . In brief, blood was centrifuged at 700 g for 30 min at 4°C with no breaks, buffy coat was collected, washed first in red blood cell lysis buffer (distilled water with 0.5 mM Na EDTA, 310 mM NH 4 Cl, 24 mM NaHCO 3 ) and then in PBS. Leukocytes were then re-suspended in RPMI-1640 supplemented with 10% fetal bovine serum (FBS) and 100 U/ml penicillin and 100 μg/ ml streptomycin (monocyte medium). Monocytes were enriched using flasks pre-incubated with autologous plasma, as previously described (Franzoni et al., 2017) . Monocytes were detached by placing flasks on ice for 1 h, centrifuged, counted and viability was assessed using a Countess Automated Cell Counter (Thermo Fisher Scientific). Cells were re-suspended in monocyte medium and were seeded in a 12 well plates (Greiner CELLSTAR, Sigma) (5 × 10 5 live cells/well, 1.5 ml/well).
To differentiate monocytes into dendritic cells (moDC), cells were cultured for 4 days at 37°C 5% CO 2 in monocyte medium supplemented with 20 ng/ml of recombinant porcine GM-CSF and 50 ng/ml of recombinant porcine IL-4 (both R&D Systems, Minneapolis, USA) (Kyrova et al., 2014) . At day 4 media was replaced and cells were cultured at 37°C 5% CO 2 for further 2 days in monocyte medium supplemented with IL-4/GM-CSF alone or with 1000 U/ml recombinant porcine IFN-α (PBL Assay Science, Piscataway, NJ, USA) and 10 ng/ml recombinant porcine TNF-α (R&D System) to induce maturation (Carrasco et al., 2004) . In defined experiments, cells were activated using IFN-α or TNF-α alone.
Confocal microscopy
Differentiation of monocytes into moDC were observed by confocal microscopy, as previously described (Kyrova et al., 2014 , Franzoni et al., 2017 . Monocytes were cultured on two-well chamber slides (Thermo Fisher Scientific) and were stained immediately or differentiated in moDC and then left untreated or matured with IFN-α/TNF-α. Cells were fixed with 4% paraformaldehyde and labelled with Hoechst for nuclear staining and Alexa Fluor 488-conjugated phalloidin (Invitrogen) to visualize actin cytoskeleton. Microscopy was performed using a Leica SP5 Confocal Microscope (Leica Microsystem) equipped with a 40X Plan-Apo 1.25 NA oil immersion objective. Images were acquired on a format of 1024 × 1024 pixel, with a line average of 2 and scan speed of 100 Hz. Images were processed with LAS AF Lite software (Leica Microsystem) for contrast and brightness adjustments. Manipulations did not change the data content.
ASFV infection of monocytes/dendritic cells and growth curves
Culture medium from monocytes and moDC cultures were removed and replaced with a multiplicity of infection (MOI) of 1 of ASFV, diluted in fresh monocyte medium free of cytokines. To evaluate ASFV growth kinetics in moDC, cells were instead infected at MOI 0.01 with the virulent 22653/14, low virulent NH/P68 or avirulent BA71V ASFV strains. Mock-infected controls were included in each experiment. After 90 min of incubation at 37°C 5% CO 2 the virus inoculum was removed, cells were washed with un-supplemented RPMI-1640 medium and fresh monocyte medium was added to the wells. Cells were incubated at 37°C 5% CO 2 and harvested after 20 h post-infection (pi). To evaluate growth kinetics, culture supernatants were instead collected at 0, 24, 48, 72 h pi. Viral infection was assessed by intracytoplasmic p72 expression using flow cytometry and culture supernatants were collected to evaluate viral titres, viral genome copies or cytokine release in response to ASFV infection. Supernatants were cleared by centrifugation at 2000×g for 3 min and stored at −80°C until analysed.
DNA extraction and real-time PCR
Viral DNA was extracted from 0.2 ml of cell culture supernatants using High Pure PCR Template Preparation Kit according to the manufacturer's protocols (Roche, Mannheim, Germany). ASFV genome copies were assessed by real-time PCR (King et al., 2003) , using the TaqMan Fast Advanced Master Mix (Applied Biosystems), 0.8 μM of sense and anti-sense primers (5′-CTG CTC ATG GTA TCA ATC TTA TCG A-3′and 5′-GAT ACC ACA AGA TCR GCC GT-3′), 0.2 μM of TaqMan probe 5′-[6-carboxy-fluorescein (FAM)]-CCA CGG GAG GAA TAC CAA CCCAGT G-3′-[6-carboxy-tetramethyl-rhodamine (TAMRA)] in a total volume of 25 μl containing 5 μl of extracted DNA. The incubation profile was established as follows: 40 cycles of denaturation at 95°C for 15 s, annealing at 58°C for 60 s, after an initial denaturation step at 95°C for 10 min. The plasmid pEX-K4-ASFV-E70p72 (Eurofins Genomics, USA) was used as the template to prepare the standard curve for the real-time PCR assay. This plasmid contains a full length ASFV p72 sequence and the copy number was calculated based on the plasmid and insert molecular weight. For each experiment, a standard curve was prepared by serial dilution (10 −1 −10 -7 copy/μl) of pEX-K4-ASFVE70p72 template DNA.
Cytofluorometric analysis of monocytes and derived dendritic cells
Cells were harvested from cultures using ice cold PBS with 2 mM EDTA, centrifuged at 2000×g for 3 min, washed in PBS and transferred to wells of a 96-well round bottom plate. Viability was assessed by staining the cells with LIVE/DEAD® Fixable Far Red Dead Cell Stain Kit (Thermo Fisher Scientific) for 30 min at 4°C and then washed twice with PBS supplemented with 2% FBS. Staining methods were then performed as previously described (Franzoni et al., 2017) . Monoclonal antibodies (mAbs) and staining reagents used to detect surface markers were: MHC class II DR (2E9/13; Bio-Rad Antibodies, Kidlington, United Kingdom), MHC class I (JM1E3; Bio-Rad Antibodies), human CD152 mouse Ig fusion protein (CD152-muIg)-RPE (Ancell, Bayport, MS, USA), CD16-RPE (G7, Thermo Scientific Pierce, Rockford, IL, USA). Staining with MHC class II DR and MHC class I mAbs was visualized by subsequent staining with RPE-conjugated goat anti-mouse IgG Fc polyclonal antibody (Thermo Scientific Pierce). Surface stained cells were fixed and permeabilized using Leucoperm, according to manufacturer's protocol (Bio-Rad Antibodies). mAbs used to detect intracellular ASFV proteins were: anti-p72-FITC (18BG3, Ingenasa) and p30-FITC (kindly provided by Dr Gian Mario De Mia, Italian ASF Reference Laboratory, CEREP, Italy). Flow cytometry analysis were performed on a FACSCalibur (BD Biosciences) and at least 5000 live monocytes/moDC were acquired. Analysis of data was performed using Cell Quest Pro Software (BD Biosciences), by gating on viable cells (Live/Dead Fixable Dead Cell Stain negative) in the monocyte/moDC population, and then assessing the staining for surface markers/ASFV proteins. Gates for ASFV proteins were set using the mock-infected controls, whereas surface markers were set using the corresponding unstained/isotype controls: unconjugated IgG1 and unconjugated and IgG2b isotype controls (both Bio-Rad Antibodies) for MHC class I and MHC class II, respectively, mouse PE-IgG1 isotype control for CD16 (ZX3, Thermo Scientific Pierce), and unstained control for CD80/86.
Analysis of the cytokine levels in culture supernatants of monocyte derived dendritic cells to ASFV infection
The simultaneous measurement of IL-1α, IL-1β, IL-6, IL-8, IL-10, IL-12, IL-18 and TNF-α in culture supernatants were performed using Porcine Cytokine/Chemokine Magnetic Bead Panel Quantikine assay (Merck Millipore, Darmstadt, Germany) and a Bioplex MAGPIX Multiplex Reader (Bio-Rad, Hercules, USA), according to the manufacturers' instructions. The measurement of IFN-β was instead performed using Swine IFN-β Do-it-Yourself ELISA kit (King Fisher Biotech, St Paul, USA), according to manufacturer's directions, and absorbance was read with an Epoch microplate reader (BioTek, Winoosky, USA).
Data analysis and statistics
Experiments were performed in duplicate (viral titres, qPCR and multiplex ELISA) or triplicate (flow cytometry and IFN-β ELISA) and repeated at least three times with different blood donor pigs. Data were presented as means with standard deviations (SD) quoted to indicate the uncertainty around the estimate of the group mean. Graphical and statistical analysis was performed using GraphPad Prism 7.02 (GraphPad Software Inc, La Jolla, USA) and Minitab (Minitab Inc., Coventry, UK). All data were checked for normality using the Anderson Darling test and analysed by the non-parametric Mann-Whitney test or Kruskal-Wallis followed by Dunn's multiple comparison test.
Results
3.1. ASFV strains of diverse virulence infect immature moDC, however, maturation with IFN-α/TNF-α enhances susceptibility to virulent but not attenuated strains Differentiation of moDC was initially assessed by confocal microscopy; they presented with an elongated phenotype with characteristic dendrites (Fig. 1A) . As expected, monocyte to moDC differentiation was accompanied by MHC II DR up-regulation and increase in forward (FSC) and size (SSC) scatter parameters (data not shown). Susceptibility of monocytes and moDC to ASFV infection was assessed by quantification of cells containing ASFV late protein p72 and viral titres in the cell culture supernatants. Cells were mock-infected or infected with the avirulent BA71V, the attenuated NH/P68 or the virulent Sardinian isolate 22653/14, using an MOI of 1. For all the isolates, immature moDC were more susceptible to ASFV infection than freshly isolated monocytes (Fig. 1) . Maturation with IFN-α/TNF-α resulted in a reduced susceptibility to infection with BA71V and to a lesser extent NH/P68. In contrast, maturation increased susceptibility to the virulent 22653/14 isolate (Fig. 1B) . To determine whether this was a strain specific effect, we tested additional virulent ASFV isolates: three genotype I (22653/ Fig. 1 . Susceptibility of porcine monocytes, immature and mature moDC to ASFV infection. Differentiation of monocytes into moDC and their maturation by treatment with IFN-α/TNF-α was morphologically assessed by confocal microscopy (original magnification 40X) (A). Monocytes, immature moDC and mature moDC (moDC + IFN-α/TNF-α) were infected with the avirulent BA71V, the low virulent NH/P68 or the virulent 22653/14 strains using an MOI of 1, alongside mock-infected controls ('mock Vero' and 'mock macro'). 20 h pi percentages of p72 + cells were evaluated using flow cytometry and viral levels in culture supernatants were assessed by titration. The mean data ± SD from four independent experiments utilizing different animals are shown (B). For each condition (BA71V, NH/P68, and 22653/14) values of IFN-α/TNF-α matured moDC were compared to the corresponding immature moDC condition, using a Mann-Whitney test; ***p < 0.001, **p < 0.01, *p < 0.05. Fig. 2 . Genotype-independent susceptibility of mature moDC to virulent ASFV. Immature moDC and IFN-α/TNF-α matured moDC (moDC + IFN-α/TNF-α) were infected with genotype I (BA71V, NH/P68, 22653/14, 28784/16, Italy/83), genotype II (Arm07) or genotype IX (Ken06) ASFV strains using an MOI of 1, alongside mock-infected controls. 20 h pi percentages of p72 + cells were evaluated using flow cytometry. The mean data ± SD from three independent experiments utilizing different animals are shown. Percentages of p72 + in mature moDC cultures were normalised to the corresponding immature moDC condition and were compared using a Mann-Whitney test; ***p < 0.001, **p < 0.01, *p < 0.05. Veterinary Microbiology 216 (2018) 190-197 14, 28784/16, Italy/83), one genotype II (Arm07) and one genotype IX (Ken06.Bus) isolates. All virulent isolates displayed an increased capacity to infect mature compared to immature moDC (Fig. 2 , Table 1 ). We next assessed if treatment of moDC with IFN-α or TNF-α alone was responsible for the observed reduction/enhancement in susceptibility to ASFV. As displayed in Fig. 3 , activation with IFN-α, but not TNF-α, decreased BA71V and NH/P68 infection, with statistically significant differences in the level of the late viral protein p72, and to a lesser degree for expression of early protein p30 by BA71V. On the contrary, TNF-α enhanced the proportion of cells expressing p30 and p72 after 22653/14 infection (Fig. 3) .
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Both NH/P68 and 22653/14 replicated efficiently in moDC, whereas the avirulent BA71V displayed a poor ability to produce infectious virus in these cells
Next, the ability of ASFV strains of diverse virulence to replicate in these cells and to produce infectious virus was analysed. The kinetic analysis of the infection of immature and mature moDC with ASFV BA71V, NH/P68 and 22653/14 was performed using an MOI of 0.01. Replication was measured by assessing both viral titres and viral genome copies numbers present in cell culture supernatants over-time. This analysis showed that the low virulence NH/P68 strain replicated most efficiently; 72 h pi almost ten-fold more genome copies and infectious virus particles were detected compared to 22653/14 (Fig. 4) . The avirulent BA71V displayed the lowest ability to replicate in moDC, with less than 10,000 TCID 50 detected 72 h pi (Fig. 4) . In accordance with what we observed with a higher MOI, also using an MOI of 0.01 BA71V and NH/P68 were sensitive to IFN-α pre-treatment moDC, but for the NH/P68 the differences were minimal. On the contrary, moDC maturation resulted in a more efficient 22653/14 replication in these cells, albeit without statistical significance (Fig. 4) .
Assessment of the modulation of functional surface marker expression on infected moDC revealed down-regulation of MHC class I by attenuated but not virulent ASFV
Immature and IFN-α/TNF-α matured moDC were infected with BA71V, NH/P68 and 22653/14 using MOI 1, alongside mock-infected controls, and 20 h pi the expression of four functional surface markers was analysed: MHC I, MHC II DR, CD80/86, CD16. Because in some pigs BA71V infection resulted in less than 10% p72 + mature moDC, it was deemed unreliable to analyse BA71V infection for that cell subset. Infection with BA71V and NH/P68, but not with the virulent 22653/14, resulted in down-regulation of MHC I on infected cells (Fig. 5) . The avirulent BA71V induced up-regulation of MHC class II DR on immature moDC, whereas all the strains up-regulated this marker on mature moDC, albeit with statistically significance only for NH/P68 (Fig. 5) . All the strains down-regulated CD16 expression on moDC. Infection did not alter CD80/86 expression on immature moDC but decreased its expression on mature moDC (Fig. 5) .
ASFV infection of immature and mature moDC does not induce a strong cytokine response
Cells were infected with ASFV using MOI 1, alongside mock-infected controls, and culture supernatants were collected 20 h pi. No statistically significant IFN-β, IL-1β, IL-6, IL-10, IL-12, IL-18, TNF-α responses were observed from infected moDC cultures, independent of strain or maturation status. Differences were observed only in the levels of IL1-α with both immature and mature moDC, releasing low levels of IL1-α in response to BA71V infection compared to mock infected controls (Fig. 6 ).
Discussion
Immunisation of pigs with attenuated ASFV strains can confer protection against related virulent viruses (Takamatsu et al., 2013; Lacasta et al., 2015; Reis et al., 2017) . The mechanisms underlying this protection are still largely unknown and probably involve several effector mechanisms (Carlson et al., 2016) . A better understanding of how ASFV interacts with the immune system is essential to develop safe and efficacious vaccines. Despite the important role that DC play in linking innate and adaptive immunity against pathogens, little is known about their interaction with ASFV. This study therefore aimed to characterise the interaction of ASFV with moDC. Since virulent ASFV isolates may possess mechanisms to impair DC function/activation, responses to infection with ASFV strains varying in virulence may differ. Consequently, we analysed the susceptibility and response of moDC to ASFV strains of diverse virulence: the virulent 22653/14, the Mean data and standard deviation (SD) of nine replicates (three technical replicates from each of three independent experiments using different pigs) are shown. Fig. 3 . Expression of early and late ASFV proteins in moDC matured with IFN-α and/or TNF-α. Immature moDC were left untreated or matured with IFN-α and/or TNF-α for 48 h and then mock-infected or infected with BA71V or NH/P68 or 22653/14. 20 h pi expression of p30 and p72 were assessed by flow cytometry. The mean data ± SD from three independent experiments utilizing different animals are shown. For both panels, values of activated moDC were compared to the corresponding immature moDC control (moDC), using a KruskalWallis test followed by Dunn's multiple comparison test; ***p < 0.001, **p < 0.01, *p < 0.05.
low virulent NH/P68 and the avirulent BA71V. The latter is highly attenuated being unable to infect swine and confer protection against homologous BA71 challenge (Monteagudo et al., 2017) . Instead, inoculation of pigs with the low virulence NH/P68 can confer protection to challenge with the highly virulent ASFV/L60 isolate and thus is considered a model to characterise mechanisms of protective immunity to ASFV (Leitão et al., 2001 ). We first focused on determining both the susceptibility of immature and IFN-α/TNF-α-matured moDC to ASFV infection and the ability of ASFV BA71V, NH/P68 and 22653/14 to replicate in these cells. We used an MOI of 1 to analyse moDC susceptibility to infection, whereas we opted for a lower MOI to study ASFV replication and production of infectious virus in these cells. Using a MOI of 1 we observed a high percentage of dead moDC 40 h pi with the attenuated BA71V (data not shown), so we opted for a lower MOI (0.01) to perform a kinetic analysis of the three ASFV strains in mature and immature moDC. All or 22653/14 strains, using an MOI 1, alongside mock-infected controls. 20 h pi, expression of surface markers (MHC I, MHC II DR, CD80/86, CD16) and p72 were assessed by flow cytometry. The mean data ± SD from three independent experiments utilizing different animals are shown. For each marker, the mean fluorescence intensity (MFI) of ASFV-infected or bystander moDC were compared to the corresponding control ('mock Vero' for BA71V and 'mock macro' for NHP/68 and 22653/14), using a Mann-Whitney test or a Kruskal-Wallis test followed by Dunn's multiple comparison test; ***p < 0.001, **p < 0.01, *p < 0.05.
strains infected immature moDC, but activation with IFN-α but not TNF-α alone resulted in an increased resistance to the attenuated strains, with NH/P68 showing a reduced sensitivity compared to the avirulent BA71V. A similar phenomenon has been observed in porcine alveolar macrophages, where pre-treatment with IFN-α reduced replication of attenuated but not virulent ASFV strains, which was attributed to gene deletions in the region containing 360/530 multi-gene families (Golding et al., 2016) . We observed that differences were mainly in the levels of late (p72) rather than early (p30) protein expression, which suggests that IFN-α inhibits ASFV infection progression. These results are in accordance with a recent study, were sensitivity of BA71V to type I IFN was described in Vero cells (Muñoz-Moreno et al., 2016) . Researchers observed that type I IFN treatment induced expression of interferon-induced trans-membrane (IFITM) proteins 1, 2, 3, and over-expression of these antiviral factors caused a reduction in the levels of both viral proteins p30 and p72 after BA71V infection, but the latter in a more marked way (Muñoz-Moreno et al., 2016) . Pre-treatment of moDC with TNF-α/IFN-α enhanced susceptibility to infection of virulent isolates, independently on their genotype, and our results suggest that this effect is mainly related to TNF-α. Although TNF-α is known as a prototype pro-inflammatory cytokine which has a key role in activation of the immune system to fight viral infection, sometimes it can instead favour viral replication. In a study on human cytomegalovirus (CMV) it was reported that addition of TNF-α promoted virus production in infected macrophages (Soderberg-Naucler et al., 1997) and a recent paper on spring viremia of carp virus (SVCV) described that this cytokine can impair viral clearance by inhibition of the host autophagic response (Espin-Palazon et al., 2016) . It can be speculated that also in porcine moDC TNF-α activation might result in the inhibition of autophagy, affecting the elimination of ASFV intracellular particles. Further experiments, especially in vivo studies, should investigate the effect of anti-TNF-α therapy during ASFV infection. Modulation of the expression of MHC class I and II and of the costimulatory molecules CD80/86 may affect antigen-presentation and development of protective adaptive immune responses. Infection with attenuated (BA71V and NH/P68) but not virulent 22653/14 resulted in down-regulation of MHC class I on infected moDC. Similar results were observed also in monocyte-derived macrophages (Franzoni et al., 2017) and in vivo this down-regulation might result in NK cell activation (Lanier, 2005) . NK cell activation may play a role in protection against ASFV and a previous study reported a correlation between NK activation and protection following NH/P68 inoculation (Leitão et al., 2001 ). Another study also described that NH/P68 but not virulent Lisbon 60 isolate is able to stimulate NK cell activity in vitro (Martins and Leitáo, 1994) and this effect could be related to down-regulation of MHC I on infected myeloid cells. The discrimination between p72 − and p72 + cells revealed that ASFV-infected mature moDC showed increased expression of MHC II DR compared to non-infected cells and this applied to all the strains tested. Increased expression of MHC class II should enhance interaction with and stimulation of T lymphocytes (McCullough and Summerfield, 2009 ), but ASFV might have developed another mechanism, such as CD80/86 down-regulation, to impair the activation of naïve T cells. As described in macrophages (Franzoni et al., 2017) , ASFV down-regulated expression of the low affinity Fc receptor CD16 also on moDC and this effect has not been lost during BA71V or NH/P68 attenuation. CD16 down-regulation might impair DC function, reducing their ability to recognise opsonized virions. Finally, we characterised the cytokine responses of porcine moDC to ASFV infection. Compared to highly virulent strains, infection of macrophages with attenuated ASFV strains results in enhanced expression and/or production of several key regulatory cytokines (IFN-α, IFN-β, TNF-α, IL-1β, IL-12, IL-18) (Gil et al., 2008 , Reis et al., 2016 , Franzoni et al., 2017 . We hypothesised that differences may also exist between moDC cytokine responses to ASFV strains varying in virulence, with possible implication in the acquisition of a protective immune response against ASFV. It was reported that NH/P68 induced higher production of TNF-α and IL-12p40 from infected macrophages than the virulent L60 (Gil et al., 2008) . In this study no release of TNF-α and IL-12 in response to ASFV infection was observed. Differences might be linked to the different myeloid cells analysed or because IL-12p40 is also a subunit of IL-23 (Duque and Descoteaux, 2014) . In a recent work it was reported that infection of macrophages with attenuated ASFV strains resulted in high levels of IFN-β mRNA compared to the virulent Benin (Reis et al., 2016 ), but we could not detect this cytokine in the supernatants of infected moDC, regardless of the virulence of the strains tested. This might be due to the different myeloid cells analysed (moDC instead of alveolar macrophages), or maybe post-transcriptional mechanisms inhibit IFN-β synthesis after mRNA production. In our previous work we reported a higher release of IL-1α, IL-1β and IL-18 from classically activated macrophages following infection with BA71V Fig. 6 . IL-1α release by moDC in response to ASFV infection. Immature moDC and IFN-α/TNF-α matured moDC (moDC + IFN-α/TNF-α) were infected with BA71V or NH/P68 or 22653/ 14 strains, using an MOI 1, alongside mock-infected controls. 20 h pi the amount of IL-1α in culture supernatants was evaluated. The mean data ± SD from three independent experiments utilizing different animals are shown. Values of ASFV-infected moDC were compared to the corresponding control ('mock Vero' for BA71V and 'mock macro' for NHP/68 and 22653/14), using a Mann-Whitney test or a Kruskal-Wallis test followed by Dunn's multiple comparison test; ***p < 0.001, **p < 0.01, *p < 0.05. compared with 22653/14 (Franzoni et al., 2017) . Also in this study a slight but statistically significant increase in the release of IL-1α was observed in response to BA71V, but not to NH/P68 or 22653/14 strains. Surprisingly no release of the eight other cytokines tested was observed, regardless of the tested strain. ASFV might have developed strategies to inhibit transcriptional and post-transcriptional synthesis of these key immunomodulatory proteins, thereby supporting covert replication in these inflammatory DC.
Conclusion
Our analyses have shown that ASFV efficiently replicates in moDC, resulting in modulation of important functional molecules and perhaps most significantly preventing the elicitation of a cytokine response. Differences between ASFV strains of diverse virulence were observed: attenuated strains were sensitive to IFN-α and infection with BA71V and NH/P68, but not 22653/14, resulted in downregulated expression of MHC class I on infected moDC, which in vivo might result in activation of protective immune responses. Collectively these data suggest that ASFV may exploit inflammatory moDC to aid its modulation/ evasion of the host cellular immune response.
